Physician profile
David Wang
NPI 1841599677
$4,604.17
in general payments reported to CMS, 2019-2025
4 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.33 · 2021: $38.34 · 2022: $76.00 · 2023: $4,265 · 2024: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,125 · Travel and Lodging: $1,057 · Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,125.00 |
| Travel and Lodging | $1,056.52 |
| Food and Beverage | $258.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $4,440.50 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.01 | 2021-2022 | |
| Octapharma USA, INC. | $49.33 | 2019 | |
| Janssen Biotech, INC. | $34.33 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.